Viewing Study NCT01709760


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-01-03 @ 6:02 AM
Study NCT ID: NCT01709760
Status: UNKNOWN
Last Update Posted: 2018-04-17
First Post: 2012-10-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA
Sponsor: Mycenax Biotech Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module